Skip to content

Study · Animal study (in vivo) · mouse · 2025

7 results

Oral nicotinamide mononucleotide (NMN) increases tissue NAD+ content in mice but neither NMN nor Polypodium leucotomos protect against UVR-induced skin cancer.

Pihl C, Kara RD, Granborg JR, Olesen UH, Bjerring P, Haedersdal M, Untracht GR, Lerche CM

Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology29 May 2025Cited by 3 (Europe PMC)

Summary

Keratinocyte carcinoma is the most common cancer. Oral photoprotection offers an attractive addition to classical prevention measures. Popular candidates include nicotinamide and nicotinamide mononucleotide (NMN), which are NAD+ precursors thought to facilitate DNA repair. Extracts from the Polypodium leucotomos plant (PL) are also reported to convey broad protection against ultraviolet radiation (UVR) in both human and animal models. In this study, we evaluated the efficacy of NMN and PL treatment to prevent UVR-induced tumor development in hairless mice. Oral treatment with NMN or PL did not affect tumor development evaluated by tumor onset, number, size, or growth. Oral NMN increased NAD+ content in skin compared to the UVR control (p ≤ 0.00039) and liver tissue compared to the UVR control and non-exposed mice (p ≤ 0.0466) with no effect on tumor growth. We also demonstrated that UVR exposure induced urinary excretion of thymidine dimers in mice as measured by liquid chromatography-mass spectrometry, indicating that the induction of photodamage can be monitored non-invasively throughout the study period.
CC BYText from Europe PMC. Highlighted sentences are the source of results.

Results from this study7

7 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In UVR-exposed hairless mice, oral NMN did not affect tumor onset.

    In plain wordsIn mice exposed to ultraviolet radiation, oral NMN did not change when tumors appeared.

    Outcome
    No significant changeTumor onset
    Study

    mousen: not reported in source

    UVR-exposed hairless mice
    Outcome group
    Tumor growth · Cancer
    Studied dose
    Dose not stated · oralAs given in this study (mouse).

    Source sentences

    Summary
    Oral treatment with NMN or PL did not affect tumor development evaluated by tumor onset, number, size, or growth.
    1 context sentence
    Summary · context
    In this study, we evaluated the efficacy of NMN and PL treatment to prevent UVR-induced tumor development in hairless mice.
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In UVR-exposed hairless mice, oral NMN did not affect tumor number.

    In plain wordsIn mice exposed to ultraviolet radiation, oral NMN did not change tumor numbers.

    Outcome
    No significant changeTumor number
    Study

    mousen: not reported in source

    UVR-exposed hairless mice
    Outcome group
    Tumor growth · Cancer
    Studied dose
    Dose not stated · oralAs given in this study (mouse).

    Source sentences

    Summary
    Oral treatment with NMN or PL did not affect tumor development evaluated by tumor onset, number, size, or growth.
    1 context sentence
    Summary · context
    In this study, we evaluated the efficacy of NMN and PL treatment to prevent UVR-induced tumor development in hairless mice.
  3. 03AnimalAnimal study (in vivo)Efficacy outcome

    In UVR-exposed hairless mice, oral NMN did not affect tumor size.

    In plain wordsIn mice exposed to ultraviolet radiation, oral NMN did not change tumor size.

    Outcome
    No significant changeTumor size
    Study

    mousen: not reported in source

    UVR-exposed hairless mice
    Outcome group
    Tumor growth · Cancer
    Studied dose
    Dose not stated · oralAs given in this study (mouse).

    Source sentences

    Summary
    Oral treatment with NMN or PL did not affect tumor development evaluated by tumor onset, number, size, or growth.
    1 context sentence
    Summary · context
    In this study, we evaluated the efficacy of NMN and PL treatment to prevent UVR-induced tumor development in hairless mice.
  4. 04AnimalAnimal study (in vivo)Efficacy outcome

    In UVR-exposed hairless mice, oral NMN did not affect tumor growth.

    In plain wordsIn mice exposed to ultraviolet radiation, oral NMN did not change tumor growth.

    Outcome
    No significant changeTumor growth
    Study

    mousen: not reported in source

    UVR-exposed hairless mice
    Outcome group
    Tumor growth · Cancer
    Studied dose
    Dose not stated · oralAs given in this study (mouse).

    Source sentences

    Summary
    Oral treatment with NMN or PL did not affect tumor development evaluated by tumor onset, number, size, or growth.
    1 context sentence
    Summary · context
    In this study, we evaluated the efficacy of NMN and PL treatment to prevent UVR-induced tumor development in hairless mice.
  5. 05AnimalAnimal study (in vivo)Efficacy outcome

    In UVR-exposed mice, oral NMN increased skin NAD+ content compared with the UVR control.

    In plain wordsIn mice exposed to ultraviolet radiation, oral NMN increased skin NAD+ compared with the radiation control.

    Outcome
    IncreaseSkin NAD+ content
    Study

    mousen: not reported in source

    UVR-exposed hairless mice
    Comparator
    UVR control
    Outcome group
    Energy expenditure and thermogenesis · Skin and wound
    Studied dose
    Dose not stated · oralAs given in this study (mouse).

    Source sentences

    Summary
    Oral NMN increased NAD+ content in skin compared to the UVR control (p ≤ 0.00039) and liver tissue compared to the UVR control and non-exposed mice (p ≤ 0.0466) with no effect on tumor growth.
    1 context sentence
    Summary · context
    In this study, we evaluated the efficacy of NMN and PL treatment to prevent UVR-induced tumor development in hairless mice.
  6. 06AnimalAnimal study (in vivo)Efficacy outcome

    In UVR-exposed mice, oral NMN increased liver NAD+ content compared with the UVR control.

    In plain wordsIn mice exposed to ultraviolet radiation, oral NMN increased liver NAD+ compared with the radiation control.

    Outcome
    IncreaseLiver NAD+ content versus UVR control
    Study

    mousen: not reported in source

    UVR-exposed hairless mice
    Comparator
    UVR control
    Outcome group
    Energy expenditure and thermogenesis · Liver
    Studied dose
    Dose not stated · oralAs given in this study (mouse).

    Source sentences

    Summary
    Oral NMN increased NAD+ content in skin compared to the UVR control (p ≤ 0.00039) and liver tissue compared to the UVR control and non-exposed mice (p ≤ 0.0466) with no effect on tumor growth.
    1 context sentence
    Summary · context
    In this study, we evaluated the efficacy of NMN and PL treatment to prevent UVR-induced tumor development in hairless mice.
  7. 07AnimalAnimal study (in vivo)Efficacy outcome

    In UVR-exposed mice, oral NMN increased liver NAD+ content compared with non-exposed mice.

    In plain wordsIn mice exposed to ultraviolet radiation, oral NMN increased liver NAD+ compared with mice without radiation exposure.

    Outcome
    IncreaseLiver NAD+ content versus non-exposed mice
    Study

    mousen: not reported in source

    UVR-exposed hairless mice
    Comparator
    non-exposed mice
    Outcome group
    Energy expenditure and thermogenesis · Liver
    Studied dose
    Dose not stated · oralAs given in this study (mouse).

    Source sentences

    Summary
    Oral NMN increased NAD+ content in skin compared to the UVR control (p ≤ 0.00039) and liver tissue compared to the UVR control and non-exposed mice (p ≤ 0.0466) with no effect on tumor growth.
    1 context sentence
    Summary · context
    In this study, we evaluated the efficacy of NMN and PL treatment to prevent UVR-induced tumor development in hairless mice.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.